NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Greystone Associates

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Greystone Research Associates Examines Recent Developments and their Potential Impact on Diabetes Management Sector - Slow but steady progress being made toward monitoring glucose noninvasively - GreystoneAssociates.org
Greystone Research Associates Examines Recent Developments and their Potential Impact on Diabetes Management Sector

 

NewswireTODAY - /newswire/ - Amherst, NH, United States, 2013/03/18 - Slow but steady progress being made toward monitoring glucose noninvasively - GreystoneAssociates.org.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

When it comes to the diabetes market, there has been no shortage of announcements and pronouncements regarding the ability and forthcoming availability of evolving technology to ease the daily burden faced by diabetes patients. The size and growth forecast for the diabetes management market make it one of the top five healthcare markets. But progress in developing and commercializing a noninvasive glucose monitor (NGM) has been frustratingly slow.

This device sector has long been characterized by small, undercapitalized companies that have struggled to solve the numerous technology issues inherent in attempting to measure analytes through intact skin across an extremely wide range of phenotypes, genotypes and body types. But in the past few years a handful of private firms working to develop NGMs based on well-established technological principles and backed by savvy investors have made progress toward the creation of monitors that are considered to be commercializable.

A comprehensive analysis of noninvasive glucose monitors is the subject of a new and comprehensive report. The report Noninvasive Glucose Monitors: Devices, Technologies, Players and Prospects - includes assessments of devices, device features, analysis of market factors, profiles of market participants and their activities, and market forecasts.

About Greystone

Greystone Research Associates (greystoneassociates.org) is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Greystone Associates

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Greystone Research Associates Examines Recent Developments and their Potential Impact on Diabetes Management Sector

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Noninvasive Glucose |
Contact: Mark Smith - GreystoneAssociates.org 
603-595-4340 mksmith[.]greystoneassociates.org
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Greystone Associates securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Greystone Associates / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Novotech Awarded by Frost & Sullivan for Global Biotech Clinical Trials Excellence in APAC
Ipsen Receives CHMP Negative Opinion for Palovarotene as A Treatment for Fibrodysplasia Ossificans Progressiva in E.U
Ipsen Presents Positive Results from the Pivotal Phase III NAPOLI 3 Trial Evaluating An Investigational Regimen of Onivyde®
SCHOTT Opens First Facility in U.S. to Increase Capabilities and Capacity for Development and Manufacturing of Diagnostics and Life Sciences Products
Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
Ipsen Demonstrates Commitment to Innovation in Neuroscience At 12th World Congress for Neurorehabilitation (WCNR)
BASF Pharma Solutions Excipient Accepted into FDA Pilot Program for Novel Excipients
Digital Technologies Drive Growth Across the Biomanufacturing Value Chain Finds Frost & Sullivan
DSM Starts Construction of Large Scale Production Facility for its Novel Methane-reducing Feed Additive for Ruminants, Bovaer® in Dalry, Scotland
Collaboration Between Drug and Medical Food Manufacturers to Boost Market Growth Says Frost & Sullivan
Parexel Recognized by Frost & Sullivan with 2022 Global Customer Value Leadership Award
Ipsen’s Global Natural History Study of Fibrodysplasia Ossificans Progressiva Shows Debilitating Impact of the Disease Over An Individual’s Lifetime
BASF and Evonik Partner to Reduce the Environmental Footprint of the Feed and Animal Protein Industries
Rely+On Virkon from LANXESS Effective Against Monkeypox Virus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  Power 1 Energy Company





 
  ©2005-2023 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)